Today's strategic buyer is highly focused on growth by buying complimentary or competing products, filling existing distribution channels with additional products or buying similar operations to exploit synergies.

Such has been the case with Valeant Pharmaceuticals International Inc. (TSE: VRX) in 2013.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.